{
  "url": "https://openlegislation.uk/misuse-of-drugs-regulations-2001/schedule-4/part-II/paragraph-2",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-regulations-2001/schedule-4/part-II/paragraph-2.json",
  "legislation": "uksi/2001/3998",
  "legislation_title": "The Misuse of Drugs Regulations 2001",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-regulations-2001",
  "path": "schedule/4/part/II/paragraph/2",
  "kind": "paragraph",
  "number": "2",
  "heading": null,
  "text": "Any compound (not being Trilostane or a compound for the time being specified in paragraph 1 of this Part of this Schedule) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say -\n(a) by further substitution at position 17 by a methyl or ethyl group;\n(b) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;\n(c) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;\n(d) by fusion of ring A with a heterocyclic system.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2001/3998/schedule/4/part/II/paragraph/2",
    "retrieved_at": "2026-10-29T07:18:47.393467+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}